“Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld

@article{Schranz2016NihilismOC,
  title={“Nihilism” of chronic heart failure therapy in children and why effective therapy is withheld},
  author={D. Schranz and N. Voelkel},
  journal={European Journal of Pediatrics},
  year={2016},
  volume={175},
  pages={445 - 455}
}
  • D. Schranz, N. Voelkel
  • Published 2016
  • Medicine
  • European Journal of Pediatrics
  • AbstractMajor advances in chronic heart failure (cHF) therapy have been achieved and documented in adult patients, while research regarding the mechanisms and therapy of cHF in children has lagged behind. Based on receptor physiological studies and pharmacological knowledge, treatment with specific ß1-adrenergic receptor blocker (ARB), tissue angiotensin-converting enzyme inhibitor (ACE-I), and mineralocorticoid antagonists have to be recommended in children despite lack of sufficient data… CONTINUE READING
    24 Citations
    Pharmacological Chronic Heart Failure Therapy in Children. Focus on Differentiated Medical Drug Support
    • Highly Influenced
    • PDF
    Pharmacological Heart Failure Therapy in Children: Focus on Inotropic Support.
    • D. Schranz
    • Medicine
    • Handbook of experimental pharmacology
    • 2019
    • 1
    The role of regenerative therapy in the treatment of right ventricular failure: a literature review
    Pulmonary Artery Banding for Ventricular Rehabilitation in Infants With Dilated Cardiomyopathy: Early Results in a Single-Center Experience
    • Highly Influenced
    • PDF

    References

    SHOWING 1-10 OF 86 REFERENCES
    Tolvaptan in a pediatric patient with diuretic‐resistant heart and kidney failure
    • 6
    Treatment of pulmonary arterial hypertension in children
    • 38
    Enalapril in Infants With Single Ventricle: Results of a Multicenter Randomized Trial
    • 190
    • PDF
    Effect of carvedilol on survival in severe chronic heart failure.
    • 2,438
    • PDF